HAEMONETICS CORP - Common stock, $0.01 par value per share (HAE)

CUSIP: 405024100

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
-143,533
Put/Call ratio
55%
SEC-reported price per share
$111.01
Number of holders
288
Value change
-$22,300,347
Number of buys
148
Open additional details 1 more signal available
Number of sells
138
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
45,420,621

Security key

405024100

Report period

Q1 2021

Institutions

288

Top holders

10

Ownership snapshot

Top reported holders of HAE - HAEMONETICS CORP - Common stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F Highest disclosed value: $669,481,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors has the largest disclosed position value at $669.48M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.
Disclosed position value Top 5
Capital Research Global Investors $669.48M
VANGUARD GROUP INC $576.21M
BlackRock Finance, Inc. $558.2M
Neuberger Berman Group LLC $335.64M
FMR LLC $294.93M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capital Research Global Investors
13F
Company
13F
—
denominator unverified
$669,481,000
5,637,735 shares
— 31 Dec 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$576,208,000
4,852,282 shares
— 31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$558,195,000
4,700,591 shares
— 31 Dec 2020
Neuberger Berman Group LLC
13F
Company
13F
—
denominator unverified
$335,642,000
2,833,049 shares
— 31 Dec 2020
FMR LLC
13F
Company
13F
—
denominator unverified
$294,934,000
2,483,654 shares
— 31 Dec 2020
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$213,286,000
1,796,091 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
288
Shares
49,961,531
Rows available
288
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders
288
Q1 2021 holders
288
Holder diff
0
Investor Q1 2021 Shares Q1 2021 Shares Share Diff Share Chg % Q1 2021 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .